The studies with the LLC NRAS KO cells propagated orthotopically in C57BL/6 mice showed that combined MRTX-849 and SHP2 inhibitor, RMC-4550, induced tumor shrinkage, albeit transiently (Figure 3). Here, NRAS is linked to neoplasm.